Reasons Why People Avoid Essential Cholesterol Medications

Select Language:

Credit: Unsplash+

Heart disease continues to be the top cause of death worldwide. In the U.S., it accounts for a death every few seconds, according to the Centers for Disease Control and Prevention.

This is largely driven by the accumulation of cholesterol in the arteries, which constricts blood flow and can trigger heart attacks and strokes.

To lower this risk, doctors frequently prescribe statins. These medications help decrease levels of low-density lipoprotein, or LDL — often called “bad” cholesterol. Elevated LDL can cause fatty deposits to develop inside blood vessels, narrowing and stiffening them over time. This process can impair heart function and damage other organs.

Statins have been extensively studied and proven to reduce the chances of heart attacks, strokes, and premature death. They are especially crucial for individuals with existing risk factors like diabetes, very high cholesterol, or a history of stroke. For these patients, statins can be instrumental in safeguarding long-term health.

Despite their benefits, recent research shows many individuals who could gain from statins are opting not to take them. A study conducted by researchers at Brigham and Women’s Hospital involved over 24,000 patients at high risk for cardiovascular disease.

All participants were advised by their doctors to start statin therapy, yet over 20% declined the medication. Surprisingly, about one-third of these patients never even attempted to start treatment.

The study found that those who forgo statins take significantly longer to bring their cholesterol to healthy levels—on average, three times longer than those who follow their healthcare provider’s advice. This delay raises their risk of future heart problems.

Published in JAMA Network Open, the study also identified gender differences: women were about 20% more likely than men to refuse statins initially and roughly 50% more likely never to begin treatment at all.

A possible reason for this is that some women still believe heart disease primarily affects men. In reality, it affects both men and women and ranks as a leading cause of death for both genders. Misunderstanding of this nature can lead women to underestimate their own risk.

Experts suggest that improving communication between healthcare providers and patients could help address these misconceptions.

Dr. Alex Turchin, one of the study’s authors, emphasized that doctors should take time to understand patients’ concerns and thoroughly explain the benefits and potential side effects of statins. This patient-centered approach helps build trust and supports informed decision-making.

Some individuals worry about side effects such as muscle pain or stomach discomfort, although serious adverse effects are rare.

Others might feel uncertain about daily medication routines or be swayed by anecdotes and online information. While these concerns are understandable, they highlight the need for open discussions with healthcare professionals.

The research team is continuing to monitor the long-term outcomes of patients who refuse statins, aiming to understand better how this choice impacts their risk for heart attacks, strokes, and early death.

While medications like statins are highly effective, they’re just one aspect of maintaining heart health. Regular exercise, a nutritious diet, and other healthy habits are also vital. Nonetheless, for individuals at high risk, statins offer substantial protection when used as directed.

Making informed health decisions is essential. If your doctor recommends statins, engage in open dialogue, ask questions, and fully understand your options. Such conversations can be key to living a longer, healthier life.

For those interested in heart health, explore studies on how eating eggs can potentially reduce heart disease risk and Vitamin K2’s role in lowering heart disease risk.

Additional resources cover recent advances in removing plaque buildup responsible for heart attacks, as well as innovative approaches to prevention, such as new treatments to avoid strokes and cardiac events.